The start of Cleaner will provide an easy, effective method for declotting occluded vessels and grafts, stated George Leondis, President of Argon Medical. This is a significant step of progress in Argon’s strategy to provide unique solutions to the interventional space, and we are assured this ‘best in class’ product will quickly turn into a leading technology in this fast-growing marketplace segment. SOURCE Argon Medical Devices, Inc.. Argon Medical Products, Rex Medical announce licensing agreement for Cleaner Rotational Thrombectomy System Argon Medical Devices, Inc. Cleaner is a medical device designed for the mechanical declotting of occluded native vessel dialysis fistulae and synthetic dialysis gain access to grafts.MacKenzie says. ‘He displays a genuine insight conceptually and also technically having very great hands at the benchtop.’.. Bristol-Myers AstraZeneca and Squibb to collaborate on Type 2 diabetes compunds Bristol-Myers Squibb and AstraZeneca have announced a collaboration to build up and commercialize two investigational substances getting studied for the treating Type 2 diabetes. Both substances were uncovered by Bristol-Myers Squibb.